Request a sample to get extensive insights into the Tuberculosis Testing Market
To understand how our report can bring difference to your business strategy, Ask for a brochure
Stuck in a neck-to-neck competition with other brands? Request a custom report on Tuberculosis Testing Market
Key players in the global tuberculosis testing Market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global tuberculosis testing Market. A few expansion strategies adopted by players operating in the global tuberculosis testing Market are:
The report on the global tuberculosis testing Market discussed individual strategies, followed by company profiles of manufacturers of tuberculosis testing Kits. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global tuberculosis testing Market.
Global Tuberculosis Testing Market – Segmentation
|
Test Type |
|
|
End-user |
|
|
Region |
|
Tuberculosis testing market to Reach US$ 3,399.8 Mn By 2027
Tuberculosis testing market is anticipated to expand at a CAGR of 4.0% from 2019 to 2027
Tuberculosis testing market is driven by rise in the prevalence of drug-resistant tuberculosis infection
North America accounted for a major share of the global tuberculosis testing market and the trend is anticipated to continue during the forecast period
Key players in the global tuberculosis testing market include Thermo Fisher Scientific, Inc., Alere, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche AG
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global tuberculosis testing market
4. Market Overview
4.1. Introduction
4.1.1. Test Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Tuberculosis Testing Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Burden of TB Worldwide
5.2. Burden of MDR-TB Worldwide
5.3. Challenges of Traditional Testing/Diagnostic Methods
5.4. Mergers & Acquisitions
6. Global Tuberculosis Testing Market Analysis and Forecast, by Test Type
6.1. Introduction & Definition
6.1.1. Key Findings / Developments
6.2. Global Tuberculosis Testing Market Value Forecast, by Test Type, 2017–2027
6.2.1. Chest X-Ray
6.2.2. Culture Based Tests
6.2.3. Interferon-Gamma Release Assays (IGRA)
6.2.4. Mantoux Test (TST)
6.2.5. Nucleic Acid Testing (NAT), Xpert test
6.2.6. Serological Tests
6.2.7. Smear Microscopy
6.2.8. Other Tests (ADA, etc.)
6.3. Global Tuberculosis Testing Market Attractiveness, by Test Type
7. Global Tuberculosis Testing Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.1.1. Key Findings / Developments
7.2. Global Tuberculosis Testing Market Value Forecast, by End-user, 2017–2027
7.2.1. Hospitals Laboratories
7.2.2. Reference Laboratories
7.2.3. Physician’s Office Laboratories
7.2.4. Academics and Research
7.2.5. Others (Home Health Agencies, etc.)
7.3. Global Tuberculosis Testing Market Attractiveness, by End-user
8. Global Tuberculosis Testing Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Global Tuberculosis Testing Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. North America Tuberculosis Testing Market Attractiveness, by Region
9. North America Tuberculosis Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. North America Tuberculosis Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
9.2.1. Chest X-Ray
9.2.2. Culture Based Tests
9.2.3. Interferon-Gamma Release Assays (IGRA)
9.2.4. Mantoux Test (TST)
9.2.5. Nucleic Acid Testing (NAT), Xpert test
9.2.6. Serological Tests
9.2.7. Smear Microscopy
9.2.8. Other Tests (ADA, etc.)
9.3. North America Tuberculosis Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027
9.3.1. Hospitals Laboratories
9.3.2. Reference Laboratories
9.3.3. Physician’s Office Laboratories
9.3.4. Academics and Research
9.3.5. Others (Home Health Agencies, etc.)
9.4. North America Tuberculosis Testing Market Value (US$ Mn) Forecast, by Country, 2017–2027
9.4.1. U.S.
9.4.2. Canada
9.5. North America Tuberculosis Testing Market Attractiveness Analysis
9.5.1. By Test Type
9.5.2. By End-user
9.5.3. By Country
10. Europe Tuberculosis Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Europe Tuberculosis Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
10.2.1. Chest X-Ray
10.2.2. Culture Based Tests
10.2.3. Interferon-Gamma Release Assays (IGRA)
10.2.4. Mantoux Test (TST)
10.2.5. Nucleic Acid Testing (NAT), Xpert test
10.2.6. Serological Tests
10.2.7. Smear Microscopy
10.2.8. Other Tests (ADA, etc.)
10.3. Europe Tuberculosis Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027
10.3.1. Hospitals Laboratories
10.3.2. Reference Laboratories
10.3.3. Physician’s Office Laboratories
10.3.4. Academics and Research
10.3.5. Others (Home Health Agencies, etc.)
10.4. Europe Tuberculosis Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Tuberculosis Testing Market Attractiveness Analysis
10.5.1. By Test Type
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Tuberculosis Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Asia Pacific Tuberculosis Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
11.2.1. Chest X-Ray
11.2.2. Culture Based Tests
11.2.3. Interferon-Gamma Release Assays (IGRA)
11.2.4. Mantoux Test (TST)
11.2.5. Nucleic Acid Testing (NAT), Xpert test
11.2.6. Serological Tests
11.2.7. Smear Microscopy
11.2.8. Other Tests (ADA, etc.)
11.3. Asia Pacific Tuberculosis Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027
11.3.1. Hospitals Laboratories
11.3.2. Reference Laboratories
11.3.3. Physician’s Office Laboratories
11.3.4. Academics and Research
11.3.5. Others (Home Health Agencies, etc.)
11.4. Asia Pacific Tuberculosis Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Asia Pacific Tuberculosis Testing Market Attractiveness Analysis
11.5.1. By Test Type
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Tuberculosis Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Latin America Tuberculosis Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
12.2.1. Chest X-Ray
12.2.2. Culture Based Tests
12.2.3. Interferon-Gamma Release Assays (IGRA)
12.2.4. Mantoux Test (TST)
12.2.5. Nucleic Acid Testing (NAT), Xpert test
12.2.6. Serological Tests
12.2.7. Smear Microscopy
12.2.8. Other Tests (ADA, etc.)
12.3. Latin America Tuberculosis Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027
12.3.1. Hospitals Laboratories
12.3.2. Reference Laboratories
12.3.3. Physician’s Office Laboratories
12.3.4. Academics and Research
12.3.5. Others (Home Health Agencies, etc.)
12.4. Latin America Tuberculosis Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America Latin America
12.5. Latin America Tuberculosis Testing Market Attractiveness Analysis
12.5.1. By Test Type
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Tuberculosis Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Middle East & Africa Tuberculosis Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
13.2.1. Chest X-Ray
13.2.2. Culture Based Tests
13.2.3. Interferon-Gamma Release Assays (IGRA)
13.2.4. Mantoux Test (TST)
13.2.5. Nucleic Acid Testing (NAT), Xpert test
13.2.6. Serological Tests
13.2.7. Smear Microscopy
13.2.8. Other Tests (ADA, etc.)
13.3. Middle East & Africa Tuberculosis Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027
13.3.1. Hospitals Laboratories
13.3.2. Reference Laboratories
13.3.3. Physician’s Office Laboratories
13.3.4. Academics and Research
13.3.5. Others (Home Health Agencies, etc.)
13.4. Middle East & Africa Tuberculosis Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Middle East & Africa Tuberculosis Testing Market Attractiveness Analysis
13.5.1. By Test Type
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix (by Tier and Size of companies)
14.2. Market Share / Position Analysis, by Company, 2018
14.3. Competitive Business Strategies
14.4. Company Profiles
14.4.1. Thermo Fisher Scientific, Inc.
14.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.1.2. Growth Strategies
14.4.1.3. SWOT Analysis
14.4.2. Alere, Inc.
14.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.2.2. Growth Strategies
14.4.2.3. SWOT Analysis
14.4.3. Becton, Dickinson and Company
14.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.3.2. Growth Strategies
14.4.3.3. SWOT Analysis
14.4.4. F. Hoffmann-La Roche AG
14.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.4.2. Growth Strategies
14.4.4.3. SWOT Analysis
14.4.5. LIONEX Diagnostics & Therapeutics GmbH.
14.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.5.2. Growth Strategies
14.4.5.3. SWOT Analysis
14.4.6. Danaher Corporation
14.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.6.2. Growth Strategies
14.4.6.3. SWOT Analysis
14.4.7. Creative Diagnostics
14.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.7.2. Growth Strategies
14.4.7.3. SWOT Analysis
14.4.8. QIAGEN
14.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.8.2. Growth Strategies
14.4.8.3. SWOT Analysis
14.4.9. Hain Lifescience GmbH.
14.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.9.2. Growth Strategies
14.4.9.3. SWOT Analysis
14.4.10. Oxford Immunotec Ltd.
14.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.10.2. Growth Strategies
14.4.10.3. SWOT Analysis
14.4.11. Hologic, Inc.
14.4.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.11.2. Growth Strategies
14.4.11.3. SWOT Analysis
14.4.12. Cepheid
14.4.12.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.12.2. Growth Strategies
14.4.12.3. SWOT Analysis
14.4.13. Akonni Biosystems, Inc.
14.4.13.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.13.2. Growth Strategies
14.4.13.3. SWOT Analysis
14.4.14. bioMerieux SA
14.4.14.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.14.2. Growth Strategies
14.4.14.3. SWOT Analysis
14.4.15. Epistem Ltd
14.4.15.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.15.2. Growth Strategies
14.4.15.3. SWOT Analysis
List of Table
Table 01:Top 10 High TB burden countries with estimated number of new TB cases globally
Table 02:Estimated number of MDR-TB among all notified TB cases in high burden countries (2018)
Table 03:TB R&D Funders by Rank in 2018
Table 04:Tuberculosis Diagnostics tests Pipeline
Table 05:Global Tuberculosis Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2027
Table 06:Global Tuberculosis Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 07:Global Tuberculosis Testing Market Size (US$ Mn) Forecast, by Region, 2017–2027
Table 08:North America Tuberculosis Testing Market Size (US$ Mn) Forecast, by Country, 2017–2027
Table 09:North America Tuberculosis Testing Market Size (US$ Bn) Forecast, by Test Type, 2017–2027
Table 10:North America Tuberculosis Testing Market Size (US$ Bn) Forecast, by End-User, 2017–2027
Table 11:Europe Tuberculosis Testing Market Size (US$ Mn) Forecast, by Country, 2017–2027
Table 12:Europe Tuberculosis Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2027
Table 13:Europe Tuberculosis Testing Market Size (US$ Bn) Forecast, by End-User, 2017–2027
Table 14:Asia Pacific Tuberculosis Testing Market Size (US$ Mn) Forecast, by Country, 2017–2027
Table 15:Asia Pacific Tuberculosis Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2027
Table 16:Asia Pacific Tuberculosis Testing Market Size (US$ Mn) Forecast, by End-User, 2017–2027
Table 17:Latin America Tuberculosis Testing Market Size (US$ Mn) Forecast, by Country, 2017–2027
Table 18:Latin America Tuberculosis Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2027
Table 19:Latin America Tuberculosis Testing Market Size (US$ Mn) Forecast, by End-User, 2017–2027
Table 20:Middle East and Africa Tuberculosis Testing Market Size (US$ Mn) Forecast, by Country, 2017–2027
Table 21:Middle East and Africa Tuberculosis Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2027
Table 22:Middle East and Africa Tuberculosis Testing Market Size (US$ Mn) Forecast, by End-User, 2017–2027
List of Figure
Figure 01:Global Tuberculosis Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2018-2027
Figure 02:Market Value Share, by Test Type (2018)
Figure 03:Market Value Share, by End User (2018)
Figure 04:Market Value Share, by Region (2018)
Figure 05:Annual Global Plan Research Funding Targets versus 2015 Funding on Tuberculosis
Figure 06:Total TB R&D Funding, 2005–2015
Figure 07:Total TB R&D Funding by Funder Category, 2015
Figure 08:Total TB R&D Funding by Funder Category, 2005–2015 (Mn)
Figure 09:Global Tuberculosis Testing Market Value Share Analysis, by Test Type, 2018 and 2027
Figure 10:Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Chest X-Ray, 2017–2027
Figure 11:Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Culture Based Tests,
Figure 12:Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by IGRA, 2017–2027
Figure 13:Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Mantoux test (TST), 2017–2027
Figure 14:Global Tuberculosis Testing Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Nucleic Acid Testing (NAT), Xpert test, 2017–2027
Figure 15:Global Tuberculosis Testing Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Serological Tests,
Figure 16:Global Tuberculosis Testing Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Smear Microscopy, 2017–2027
Figure 17:Global Tuberculosis Testing Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Other Tests (ADA, etc.), 2017–2027
Figure 18:Global Tuberculosis Testing Market Attractiveness, by Test Type, 2017-2025
Figure 19:Global Tuberculosis Testing Market Value Share Analysis, by End-User, 2018 and 2027
Figure 20:Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017–2027
Figure 21:Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Reference Laboratories, 2017–2027
Figure 22:Europe Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Physician’s Office Laboratories, 2017–2027
Figure 23:Europe Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Academics and Research, 2017–2027
Figure 24:Europe Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027
Figure 25:Global Tuberculosis Testing Market Attractiveness, by End-User, 2017-2025
Figure 26:Global Tuberculosis Testing Market Revenue (US$ Bn) Forecast, 2017–2027
Figure 27:Global Tuberculosis Testing Market Value Share Analysis, by Region, 2018 and 2027
Figure 28:Global Tuberculosis Testing Market Attractiveness, by Region, 2017-2025
Figure 29:North America Tuberculosis Testing Market Size (US$ Bn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 30:North America Tuberculosis Testing Market Attractiveness Analysis, by Country, 2018-2027
Figure 31:North America Tuberculosis Testing Market Value Share Analysis, by Country, 2018 and 2027
Figure 32:North America Tuberculosis Testing Market Value Share Analysis, by Test Type, 2018 and 2027
Figure 33:North America Tuberculosis Testing Market Value Share Analysis, by End-User, 2018 and 2027
Figure 34:North America Tuberculosis Testing Market Attractiveness Analysis, by Test Type, 2018-2027
Figure 35:North America Tuberculosis Testing Market Attractiveness Analysis, by End-User, 2018-2027
Figure 36:Europe Tuberculosis Testing Market Size (US$ Bn) Forecast, 2017–2027
Figure 37:Europe Market Attractiveness Analysis, by Country, 2018-2027
Figure 38:Europe Tuberculosis Testing Market Value Share Analysis, by Country, 2018 and 2027
Figure 39:Europe Tuberculosis Testing Market Value Share Analysis, by Test Type, 2018 and 2027
Figure 40:Europe Tuberculosis Testing Market Value Share Analysis, by End-User, 2018 and 2027
Figure 41:Europe Tuberculosis Testing Market Attractiveness Analysis, by Test Type, 2018-2027
Figure 42:Europe Tuberculosis Testing Market Attractiveness Analysis, by End-User, 2018-2027
Figure 43:Asia Pacific Tuberculosis Testing Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 44:Asia Pacific Tuberculosis Testing Market Attractiveness Analysis, by Country, 2018-2027
Figure 45:Asia Pacific Tuberculosis Testing Market Value Share Analysis, by Country, 2018 and 2027
Figure 46:Asia Pacific Tuberculosis Testing Market Value Share Analysis, by Test Type, 2018 and 2027
Figure 47:Asia Pacific Tuberculosis Testing Market Value Share Analysis, by End-User, 2018 and 2027
Figure 48:Asia Pacific Tuberculosis Testing Market Attractiveness Analysis, by Test Type, 2018-2027
Figure 49:Asia Pacific Tuberculosis Testing Market Attractiveness Analysis, by End-User, 2018-2027
Figure 50:Latin America Tuberculosis Testing Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 51:Latin America Tuberculosis Testing Market Attractiveness Analysis, by Country, 2018-2027
Figure 52:Latin America Tuberculosis Testing Market Value Share Analysis, by Country, 2018 and 2027
Figure 53:Latin America Tuberculosis Testing Market Value Share Analysis, by Test Type, 2018 and 2027
Figure 54:Latin America Tuberculosis Testing Market Value Share Analysis, by End-User, 2018 and 2027
Figure 55:Latin America Tuberculosis Testing Market Attractiveness Analysis, by Test Type, 2018-2027
Figure 56:Latin America Tuberculosis Testing Market Attractiveness Analysis, by End-User, 2018-2027
Figure 57:Middle East and Africa Tuberculosis Testing Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 58:Middle East and Africa Tuberculosis Testing Market Attractiveness Analysis, by Country, 2018-2027
Figure 59:Middle East and Africa Tuberculosis Testing Market Value Share Analysis, by Country, 2018 and 2027
Figure 60:Middle East and Africa Tuberculosis Testing Market Value Share Analysis, by Test Type, 2018 and 2027
Figure 61:Middle East and Africa Tuberculosis Testing Market Value Share Analysis, by End-User, 2018 and 2027
Figure 62:Middle East and Africa Tuberculosis Testing Market Attractiveness Analysis, by Test Type, 2018-2027
Figure 63:Middle East and Africa Tuberculosis Testing Market Attractiveness Analysis, by End-User, 2018-2027
Figure 64:Thermo Fisher Scientific, Inc.- Breakdown of Net Sales (% Share), by Business segments (2018)
Figure 65:Thermo Fisher Scientific, Inc.- Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 66:Alere, Inc.- Revenue Split, by Operating Segment, 2015
Figure 67:Alere, Inc. - Total Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2018
Figure 68:Becton, Dickinson and Company - Breakdown of Net Sales, by Region, 2018
Figure 69:Becton, Dickinson and Company- Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 70:F. Hoffmann-La Roche AG Breakdown of Net Sales (Pharmaceutical Division), by Region, 2015
Figure 71:F. Hoffmann-La Roche AG- Revenue (US$ Bn) & Y-o-Y Growth (%), 2015–2018
Figure 72:Danaher Corporation - Breakdown of Revenue, by Region, 2018
Figure 73:Danaher Corporation - Revenue (US$ Bn) & Y-o-Y Growth (%), 2012–2018
Figure 74:QIAGEN- Breakdown of Net Sales, by Business Segment, 2018
Figure 75:QIAGEN- Revenue (US$ Bn) and Y-o-Y Growth (%), 2015–2018
Figure 76:Oxford Immunotec Ltd.- Breakdown of Net Sales, by region, 2015
Figure 77:Oxford Immunotec Ltd. - Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2018
Figure 78: Hologic, Inc. - Breakdown of Net Sales, by Country/Region, 2015
Figure 79:Hologic, Inc. - Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 80:Cepheid - Breakdown of Net Sales, by Country/Region, 2015
Figure 81:Cepheid - Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 82:bioMerieux SA - Breakdown of Net Sales, by Country/Region, 2018
Figure 83:bioMerieux SA - Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 84:Epistem Ltd. - Breakdown of Net Sales, by Country/Region, 2015
Figure 85:Epistem Ltd. - Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Tuberculosis Testing Market
*86 figures and 60 tables includes